According to
Data Bridge Market Research new Market report “Global Bleeding Disorders Treatment Market, By Type (Hemophilia A, Hemophilia B,
VWD); Drug Class (Plasma Derived Coagulation Factor Concentrates, Recombinant
Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin
Sealant); Geography (North America, Europe, Asia-Pacific, Europe, South
America, Middle East and Africa) – Trends and Forecast to 2024”, the global
bleeding disorder treatment market
accounted to USD 12.4 billion in 2016 at a CAGR of 11.1% during the
forecast period of 2017 to 2024.
Ask for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-bleeding-disorders-treatment-market
This report consists of below pages:
·
No of pages: 350
·
No of Figures: 60
·
No of Tables: 220
Key Market points:
The market is
driven by the rising number of diagnosed patients who are suffering from
bleeding disorders worldwide and the growing awareness related to bleeding
disorder among the population. In 2016, according to American Society of
Hematology, around 20,000 people were suffering from hemophilia and von
Willebrand disease, types of bleeding disorders in U.S.
According to US
Centers for Disease Control and Prevention (CDC), nearly 400 newborns suffer
from hemophilia every year in U.S. In many developed countries, government has
taken many initiatives regarding the development of wide network of treatment
centers for bleeding disorders. Technological advancement and continuous
research and development of new drugs for bleeding disorders by the
pharmaceutical companies will definitely fuel the growth of the bleeding
disorder treatment market.
North America
dominated the market with the largest market share in 2016 whereas Asia Pacific
is expected to grow with the highest CAGR in the forecast period 2017-2024 due
to emerging economies like India and China and availability of low price of
related drugs.
Global
Bleeding Disorders Treatment Market - Geographical Segmentation:
·
North America
·
South America
·
Europe
·
Asia-Pacific
·
Middle East and Africa
Inquiry
before buying about Global Bleeding Disorders Treatment Market visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-bleeding-disorders-treatment-market
Global Bleeding Disorders Treatment
Market– Market Segmentation:
The global bleeding disorder
treatment marketis segmented on the basis of types and drug class.
·
Type
Ø Hemophilia A
Ø Hemophilia B
Ø Von Willebrand Disease (VWD)
·
Drug Class
Ø Plasma Derived Coagulation Factor Concentrates
Ø Recombinant Coagulation
Factor Concentrates
Ø Desmopressin
Ø Antifibrinolytics
Ø Fibrin Sealant
Global
Bleeding Disorders Treatment Market – Competitive Landscape:
The global bleeding
disorder treatment market report contains an in-depth profiling of the key
market players, along with the recent developments (new product launches,
partnerships, agreements, collaborations, and joint ventures) and strategies
adopted by them to sustain and strengthen their position in the market. The
report also covers the market shares for global, North America, Europe,
Asia-Pacific, Middle East and Africa and South America bleeding disorder
treatment market.
Some of the major players
operating in global bleeding disorders treatment market are Shire (U.S.),
Baxter (U.S), CSL Behring (U.S.), Alnylam Pharmaceuticals, Inc.(U.S), Bayer AG (Germany), Novo Nordisk A/S
(Denmark), Pfizer Inc. (U.S.), Xenetic Biosciences, Inc. (U.S), Biogen (U.S.), Bristol-Myers Squibb Company
(U.S),Octapharma (Switzerland), Sanofi (France), Amgen, Inc.(U.S), Bioverativ
(U.S), Janssen Global Services, LLC(U.S), Cangene Corporation (Canada), and CSL
Behring (U.S) among others.
View
Full Report Visit @ http://databridgemarketresearch.com/reports/global-bleeding-disorders-treatment-market/
Related
Report
Global
Pen Needles Market – Industry Trends and Forecast to 2024
Global Pen Needles
Market, By Product Type (Standard Pen Needles, Safety Pen Needles), By Product
Length (Nano Length, Medium Length, Long length), By Usability (Reusable Pen
Needles, Disposable Pen Needles), By Application (Diabetes, Growth Hormone
Deficiency, Others), By Therapy (Insulin, Glucagon-like peptide-1, Growth
Hormones), By End-User (Hospitals, Clinics, OTC, Home Healthcare, Others), By
Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the
World) – Industry Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Vishal
Dixit
Data
Bridge Market Research
Tel:
+1-888-387-2818